The present technology relates to a patient interface, or mask, system for treatment of sleep disordered breathing (SDB).
Treatment of sleep disordered breathing (SDB), such as obstructive sleep apnea (OSA), by continuous positive airway pressure (CPAP) flow generator systems involves the continuous delivery of air (or other breathable gas) pressurized above atmospheric pressure to the airways of a human via a conduit and a mask. Typically, the mask fits over or in the mouth and/or nose of the patient. Pressurized air flows to the mask and to the airways of the patient via the nose and/or mouth. Pressurized air is delivered to the mask by a conduit connected to the CPAP device and the mask.
The mask should be comfortable and unobtrusive so that a patient may tolerate therapy and maintain usage. Some patients may prefer a pillows or prongs type mask (as known in the art), or a nasal mask or a full face mask. Some patient's may prefer to use one or a combination of these masks interchangeably. However, this would require the purchase of a number of different mask systems, which may be expensive and/or may not be covered by insurance.
In addition, masks including oro-nasal masks typically include a rigid frame. Patients may not find this comfortable. The frame may also dislodge the sealing portion of the mask away from the face of the patient if it is contacted or forced by bed clothing, pillows, etc.
One aspect of the present technology relates to patent interface, or mask, systems that provide integrated nose and mouth seals that are less obtrusive than currently available systems.
Another aspect of the present technology relates to patient interface systems that have reduced part counts compared to currently available systems.
A further aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that provide a visible mouth region of the patient.
Still another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that do not obstruct the patient's line of sight.
Further aspects of the present technology relate to patient interface systems, for example oro-nasal masks, that are easier and/or more intuitive to assemble, fit, and use by patients, dealers, and clinicians, and provide improved fitting and sealing.
Yet another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that provide size selection from remote locations, and without assistance and/or instruction.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that are considered physiologically non-threatening and will increase patient selection of the system and adherence to therapy.
Further aspects of the present technology relate to patient interface systems, for example oro-nasal masks, that seal the mouth and nasal airways but have no nasal bridge touch points and/or fewer total points of contacts with the patient's face than current systems.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises a substantially planar fascia that may provide a visible mouth region of the patient.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises a substantially curved and/or smooth fascia that may provide a visible mouth region of the patient.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises a substantially curved and/or smooth fascia that may have no ridges, connector portions or other obstructions in the region of the patient's mouth, so that the fascia may provide a visible mouth region of the patient.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises a substantially smooth fascia that may have no complex shapes, connector portions or other obstructions in the region of the patient's mouth, so that the fascia may provide a visible mouth region of the patient.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises an air delivery tube connection, the air delivery tube connection positioned on the cushion.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that comprises an air delivery tube connection, the air delivery tube connection positioned on the fascia and offset from the centre of the fascia, that may provide a visible mouth region of the patient.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that are substantially comprised of flexible components.
Another aspect of the present technology relates to patient interface systems, for example oro-nasal masks, that are stabilised at the nose sealing portion separately to the mouth sealing portion.
A patient interface structure for delivery of respiratory therapy to a patient according to an example embodiment of the present technology comprises a front plate configured to conform to the shape of the patient's face; a mouth cushion defining a breathing chamber and provided to the front plate and configured to seal around the patient's mouth; and a nasal cushion configured to seal the patient's nasal airways, wherein the nasal cushion is supported by the mouth cushion, does not contact a bridge of the patient's nose in use, and extend at least partially into the breathing chamber.
A patient interface structure for delivery of respiratory therapy to a patient according to an example embodiment of the present technology comprises a front plate configured to conform to the shape of the patient's face; a mouth cushion defining a breathing chamber and provided to the front plate and configured to seal around the patient's mouth; and a nasal cushion configured to seal the patient's nasal airways, wherein the nasal cushion is supported by the mouth cushion, does not contact a bridge of the patient's nose in use, and is raised above the breathing chamber.
A patient interface system according to an example embodiment of the present technology comprises a patient interface structure according to the present technology and a patient interface structure positioning system configured to position, stabilize and secure the patient interface structure in sealing engagement with the patient's face.
A patient interface system according to an example embodiment of the present technology comprises a cushion adapted to sealingly engage with a patient's airways, the cushion comprising a slot adapted to receive a headgear connecting portion of a fascia.
Other aspects, features, and advantages of this technology will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this technology.
The accompanying drawings facilitate an understanding of the various embodiments of this technology. In such drawings, in which like reference symbols indicate like features:
The following description is provided in relation to several embodiments which may share common characteristics and features. It is to be understood that one or more features of any one embodiment may be combinable with one or more features of the other embodiments. In addition, any single feature or combination of features in any of the embodiments may constitute additional embodiments.
In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.
The term “air” will be taken to include breathable gases, for example air with supplemental oxygen. It is also acknowledged that the blowers described herein may be designed to pump fluids other than air.
Patient Interface Systems
Referring to
Patient Interface Positioning System
The patient interface positioning system 30 comprises a crown strap 31 adapted to cup or encircle the crown of the patient's head. Top side (or upper side straps) 32 extend from the crown strap 31 and connect to the front plate 21 through slots 27. The ends 33 of the top side straps 32 may be looped through the slots 27 and connect to the top side straps 32 by, for example, hook and loop material. It should also be appreciated that other connections, for example buckles, may be used to secure the ends 33 of the top side straps 32. The top side straps 32 may be thickened or widened at the region where they connect to the crown strap 31 to allow ends 33 a larger space to connect to and also a range of angles to position ends 33 relative to slots 27, thereby improving the fit range of the headgear 30. Such an arrangement may also improve comfort and/or to assist in stabilizing and positioning the top side straps 32 on the patient's cheek bone regions.
The crown strap 31 may further comprise a loop 40 through which a right bottom, or lower side strap 35 may pass and connect to a left bottom, or lower side strap 34. It should also be appreciated that the loop may be formed in the lower strap(s) 34 and/or 35, for example as shown in U.S. Applications 61/443,623 and 61/457,981, each of which is incorporated by reference herein in its entirety. It should further be appreciated that other headgear may be used with the patient interface system, for example as disclosed in U.S. Patent Application Publication 2008/0110466 A1, the entire contents of which are incorporated herein by reference. The bottom right side strap 35 may comprise a first end 38 in the form of a loop or slot and a first end 36 of the bottom left side strap 34 may connect to the first end 38 by passing through the loop or slot and connecting through hook and loop material or buckles or other connectors. The second end 37 of the bottom left side strap 34 and the second end 39 of the bottom right side strap 35 may be connected to the front plate 21 through slots 26 in the connectors 22.
Headgear 30 may be formed from a composite e.g. fabric and foam, which may be flame laminated and may be ultrasonically die cut or welded along its edge to create a rounded, more comfortable edge.
Front Plate/Fascia/Lens
The front plate 21 is configured to conform to or accommodate the shape of the patient's face. The front plate 21 may be flexible to allow the front plate to follow the shape of the patient's face. The front plate 21 may be formed of, for example, a flexible polymer that is able to bend and conform around the patient's mouth once the front plate 21 is connected to the patient interface positioning system 30 and fitted to the patient. The front plate 21 may also be malleable to allow the front plate to conform to the shape of the patient's face. A rib(s) 28 may be provided to the front plate 21. The ribs 28 may be provided along the top and bottom of the front plate 21 and aid in alignment and engagement with the cushion 23, as well as providing strength to the fascia.
Front plate 21 may be substantially planar, curved and/or smooth. Masks known in the art tend to include complex shapes and/or structures on the frame, and these complex shapes and/or structures make it difficult to see the patient's mouth clearly and to clean the frame. For example, these complex shapes and/or structures may include elbows, elbow connectors, ports, ridges, contours, headgear connectors, etc. Front plate 21 is adapted to be substantially smooth and without complex shapes or structures i.e. having a substantially planar surface in the region of the patient's mouth, to act as a window to permit clear visibility to the patient's mouth.
As shown on
The fascia or lens or front plate 21 is positioned in front of the patient's mouth, and is adapted to provide support to the other components of the patient interface system 10 and aid in positioning these other components, for example the front plate has headgear connectors 22 and a cushion connection portion adapted to receive the patient interface positioning system 30 and a cushion 23 and position these components relative to one another. The front plate 21 also provides some structure to the patient interface system 10 due to the comparatively greater rigidity of the front plate 21 when compared to the cushion 23.
The front plate 21 may take the form of a lens made from a clear material such as nylon, polycarbonate or nearly clear material such as polypropylene. The lens may be shaded, selectively shaded (e.g. gradient, patterned, random assortment of shapes), printed on or otherwise coloured. The lens may also have colour changing properties e.g. it may be clear when the light is on, and may be opaque when the light it off. The lens may also be customizable. The lens may be provided with a skin or adhesive layer that may customize or otherwise alter the lens. The lens may be surface treated e.g. frosted. The lens may be die cut, drape formed, vacuum formed, molded, cast, ultrasonically cut or formed in any other method to create the desired shape. The lens may also be formed with vent holes. The vent holes may be molded in, laser cut or otherwise formed with the lens. The lens may be flexible or capable of being shaped to fit the patient's face.
Cushion/Seal
Referring to
The cushions 23, 24 may be made from a single material such as silicone, TPE, TPU. However, combinations of materials and/or hardnesses of materials may be used. For example, the mouth seal or cushion 23 may have a TPE or silicone body, with a seal portion or flap adapted to interface with the patient. The nasal seal 24 may comprise a seal portion formed of an alternative material, for example a lower hardness silicone, TPU, fabric, etc.
Referring to
It should be appreciated that the mouth cushion 23 may be insert, over, or co-moulded to the front plate 21. It should be further appreciated that a cushion clip may be provided to the cushion to clip to the front plate 21. The clip may be insert, over, or co-moulded into the cushion 23 as one part. The cushion clip may add stiffness and rigidity to the cushion 23 where required, provide patient interaction points, and allow for a locating and attaching method of the cushion 23 to the front plate 21, e.g. the cushion clip may snap onto the front plate 21. The cushion clip may simplify the process of attaching the cushion 23 to the front plate 21 by reducing stretching and warping of the cushion 23 during assembly.
Slots 234 are provided in side walls 233 of the cushion 23 and are adapted to receive the connectors 22 of the front plate 21. Slots 234 may be generally rectangular, however any other shape may be possible, such that slots 234 may be complimentary to the shape of connectors 22. Connectors 22 may sealingly engage with side walls 233, for example side walls 233 may comprise a lip seal or other arrangement adapted to seal against connectors 22.
The upper portion 237 of the mouth seal or cushion 23 has a greater depth when compared with the lower portion 239 of the mouth seal or cushion 23, i.e. the distance of the seal portion to the clip portion of the upper portion may be longer than the distance from the seal portion to the clip portion of the lower portion, to tilt the cushion 23 when in use to reduce the profile of the mask 20 when in use. The upper portion 237 of the mouth seal or cushion 23 may also have a greater depth than the lower portion 239 to accommodate nasal seal or cushion 24 and patients with long noses.
Flaps 252 are provided on nares support portions 235 to assist in positioning and stabilizing the nasal seal or cushion 24 to engage with the sides of the patient's nose or the patient's top lip. Raised portions 253 on the nares support portion 235 aid in positioning the nasal seal 24 against the flares of the patient's nostrils. A connecting structure 254 in the form of indents or apertures is formed in the nasal support portions 235 and are adapted to receive lugs 241 on nasal seal or cushion 24 to aid in alignment.
A channel 251 may be provided around the nares support portions 235 to form a flexible region (e.g. could be localized thinning of material) adapted to permit movement of the nasal seal or cushion 24 to accommodate varying anthropometrics.
The side walls 233 of the mouth seal or cushion 23 may have a “question mark” cross section, i.e. the mouth seal portion does not have a straight wall section but rather has a gusseted side wall that acts as a built-in spring so that the mouth seal portion can flex to fit varying patient anthropometrics. Such a side wall cross section is disclosed in, for example, U.S. Patent Application Publication 2008/0110464 A1, the entire contents of which are incorporated herein by reference.
The front portion 238, the side walls 233 and the flap 232 of the mouth cushion 23 may have different hardnesses. For example, the front portion 238 may have a Shore A durometer of about 30-50, for example about 40. The side walls 233 and/or the flap 232 may have a Shore A durometer of 5-10, for example about 7.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
Cushion/Seal—Cushion Clip
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
The patient contacting portion of the nose and/or mouth cushions may be about 0.3-1.5 mm thick. Preferably, patient contacting portion of the nose and/or mouth cushions may be about 0.3-0.7 mm thick. Such a thickness may ensure conformability of the cushion and comfort for the patient.
Referring to
Referring to
As shown in, for example,
As shown in, for example,
Referring to
As shown in
Cushion Assembly—Continuous Sealing Surface
Referring to
Cushion Assembly—Separate Sealing Surfaces
Referring to
Patient Interface Systems—Tube Connection—Behind Connector
Referring to
The tube connection portion of the elbow 29 is adapted to receive the tube 11 in a longitudinal (e.g. vertical) direction, however other orientations are possible. The elbow 29 is not visible from the front as it is hidden behind the headgear connector 22 of the front plate 21. This arrangement is advantageous as it is reduces the part count (i.e. no separate elbow is required) and the design may be more visually appealing. The tube 11 is connected at the side of the patient interface or mask system 10 so as to permit clear view to the patient's mouth. Because the tube connection is positioned behind the headgear connector 22 at the front plate 21, the tube 11 is less obtrusive. The eyes 4 of the patient 1 are unobstructed and in the case of the front plate 21 being in the form of a lens, for example a clear polymer (e.g. polycarbonate), the patient's mouth would also be visible.
The elbow 29 may comprise a lip or protruding edge 41, in the form of for example a chamfer, adapted to receive a slot or aperture of the cushion. The cushion 23 may comprise a slot that may be positioned to abut or align with the chamfer to aid alignment, and also ensure an air tight seal between the cushion 23 and the front plate 21 is achieved.
The patient interface structure 20 sits under the patient's nose 3 and the nasal cushion 24 seals around or in the nares. The mouth cushion 23 sits in the crease of the patient's chin 5. The crown strap 31 of the headgear 30 is positioned over the top of the patient's crown and generally in line with the patient's ears 2, although it should be appreciated that the positioning of the crown strap 31 may vary between patients.
Although the front plate 21 shown in
Referring to
Patient Interface Systems—Tube Connection—Front Surface
Referring to
A tube may connect directly to the tube connector 42 or may have an intermediate structure such as an elbow or swivel between the tube and the tube connector 42, possibly shaped to avoid the tube obscuring the headgear connector 22. The tube connector 42 may have vent holes 25 molded or otherwise formed in it. The tube connector 42 may also have a lip or protruding edge 43, which may aid in sealing the tube connector 42 to the tube or intermediate structure. The tube connector 42 may have an anti-asphyxia valve (AAV) in form of a flap built in (described in more detail below) that may occlude or block some of the vent holes 25 when air is delivered from the tube and through the tube connector 42. When air pressure is not supplied, the AAV may flip away from the vent holes to permit the patient to breath in sufficient atmospheric air.
The rear face of the front plate 21 may have an aperture 44 adapted to permit the flow of air from the tube connector into the mask. The vents 25 may have a thicker cross section than the rest of the tube connector 42 (e.g. they are on a raised rectangular portion) to improve manufacturability. This may also be to increase the length of the vent holes 25 as longer vent holes are typically quieter than comparatively shorter vent holes. The tube connector 42 may follow the same general curvature of the front plate to reduce the visual bulk (i.e. more streamlined look) of the mask and aid in tube management.
Patient Interface Systems—Tube Connection—Elbow
Referring to
Patient Interface Systems—Vents
Referring to
Referring to
Referring to
Patient Interface Systems—Tube Cuff
Referring to
Referring to
Referring to
Patient Interface Systems—Anti-Asphyxia Valves (AAV)
Referring to
Referring to
Referring to
Patient Interface Systems—Materials
Referring to
Patient Interface Systems—Headgear Strap and Tube Attachment
Referring to
Patient Interface Structure—Patient Interface Positioning System Connection
Referring to
Patient Interface Structure—Fascia
The fascia, frame or lens portion may comprise a fixed elbow connection, the elbow connection directed horizontally. Such an arrangement can be seen in, for example,
While the technology has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.
This application is a continuation of U.S. application Ser. No. 17/933,504, filed Sep. 20, 2022, now allowed, which is a continuation of U.S. application Ser. No. 17/509,221, filed Oct. 25, 2021, now U.S. Pat. No. 11,464,931, which is a continuation of U.S. application Ser. No. 17/330,490, filed May 26, 2021, which is a continuation of U.S. application Ser. No. 16/032,722, filed Jul. 11, 2018, now U.S. Pat. No. 11,045,619, which is a continuation of U.S. application Ser. No. 14/645,457, filed Mar. 12, 2015, now U.S. Pat. No. 10,052,448, which is a continuation of U.S. application Ser. No. 13/876,624, now U.S. Pat. No. 9,010,330, filed Mar. 28, 2013, which is the U.S. national phase of International Application No. PCT/AU2011/001258 filed 30 Sep. 2011 which designated the U.S. and claims the benefit of U.S. Provisional Applications 61/388,357, 61/443,623, 61/457,981, and 61/528,524, filed Sep. 30, 2010, Feb. 16, 2011, Jul. 27, 2011, and Aug. 29, 2011, respectively, the entire contents of each being incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
1192186 | Greene | Jul 1916 | A |
1229050 | Donald | Jun 1917 | A |
1362766 | McGargill | Dec 1920 | A |
1445010 | Feinberg | Feb 1923 | A |
2415846 | Eugene | Feb 1947 | A |
3682171 | Dall et al. | Aug 1972 | A |
4248218 | Fischer | Feb 1981 | A |
4263908 | Mizerak | Apr 1981 | A |
4676236 | Piorkowski | Jun 1987 | A |
5005571 | Dietz | Apr 1991 | A |
5375593 | Press | Dec 1994 | A |
5438981 | Starr | Aug 1995 | A |
5513634 | Jackson | May 1996 | A |
5560354 | Berthon-Jones et al. | Oct 1996 | A |
5662101 | Ogden | Sep 1997 | A |
5921239 | McCall et al. | Jul 1999 | A |
6119694 | Correa et al. | Sep 2000 | A |
6123071 | Berthon-Jones et al. | Sep 2000 | A |
6192886 | Rudolph | Feb 2001 | B1 |
6412481 | Bienvenu et al. | Jul 2002 | B1 |
6418928 | Bordewick et al. | Jul 2002 | B1 |
6584975 | Taylor | Jul 2003 | B1 |
6631718 | Lovell | Oct 2003 | B1 |
6644315 | Ziaee | Nov 2003 | B2 |
6860270 | Sniadach | Mar 2005 | B2 |
7152602 | Bateman | Dec 2006 | B2 |
7174575 | Scherer | Feb 2007 | B1 |
7174893 | Walker et al. | Feb 2007 | B2 |
7219669 | Lovell et al. | May 2007 | B1 |
7353827 | Geist | Apr 2008 | B2 |
7448386 | Ho | Nov 2008 | B2 |
7509958 | Amarasinghe et al. | Mar 2009 | B2 |
7523754 | Lithgow et al. | Apr 2009 | B2 |
7658189 | Davidson | Feb 2010 | B2 |
7909035 | Thornton | Mar 2011 | B2 |
8028699 | Ho et al. | Oct 2011 | B2 |
8042538 | Ging et al. | Oct 2011 | B2 |
8402971 | Scheiner | Mar 2013 | B2 |
8550084 | Ng et al. | Oct 2013 | B2 |
9010330 | Barlow et al. | Apr 2015 | B2 |
9895503 | Jones et al. | Feb 2018 | B2 |
10052448 | Barlow et al. | Aug 2018 | B2 |
10130785 | Dravitzki et al. | Nov 2018 | B2 |
10245403 | Lang et al. | Apr 2019 | B2 |
10265492 | Amarasinghe et al. | Apr 2019 | B2 |
10449317 | Barlow et al. | Oct 2019 | B2 |
10456545 | Barlow et al. | Oct 2019 | B2 |
10537696 | Barlow et al. | Jan 2020 | B2 |
10596342 | Biener et al. | Mar 2020 | B2 |
10758698 | Eves et al. | Sep 2020 | B2 |
11045619 | Barlow et al. | Jun 2021 | B2 |
11052211 | Ng et al. | Jul 2021 | B2 |
11077272 | Veliss et al. | Aug 2021 | B2 |
11369765 | D'Souza et al. | Jun 2022 | B2 |
11395893 | Ng et al. | Jul 2022 | B2 |
11406784 | Berthon-Jones et al. | Aug 2022 | B2 |
11433207 | Gunaratnam et al. | Sep 2022 | B2 |
11464931 | Barlow et al. | Oct 2022 | B2 |
20020134388 | Chang | Sep 2002 | A1 |
20030172936 | Wilkie | Sep 2003 | A1 |
20040067333 | Amarasinghe | Apr 2004 | A1 |
20050121030 | Bateman | Jun 2005 | A1 |
20050199240 | Hall | Sep 2005 | A1 |
20060112962 | Tebbutt | Jun 2006 | A1 |
20060124131 | Chandran | Jun 2006 | A1 |
20060174887 | Chandran et al. | Aug 2006 | A1 |
20060207597 | Wright | Sep 2006 | A1 |
20060237017 | Davidson et al. | Oct 2006 | A1 |
20060283461 | Lubke | Dec 2006 | A1 |
20070006879 | Thornton | Jan 2007 | A1 |
20070125385 | Ho et al. | Jun 2007 | A1 |
20070186930 | Davidson et al. | Aug 2007 | A1 |
20070272249 | Chandran | Nov 2007 | A1 |
20080110466 | Armitstead | May 2008 | A1 |
20090032026 | Price et al. | Feb 2009 | A1 |
20090038619 | Ho et al. | Feb 2009 | A1 |
20090050156 | Ng et al. | Feb 2009 | A1 |
20090078259 | Kooij et al. | Mar 2009 | A1 |
20090114229 | Frater et al. | May 2009 | A1 |
20090159084 | Sher | Jun 2009 | A1 |
20090277452 | Lubke et al. | Nov 2009 | A1 |
20100018534 | Veliss et al. | Jan 2010 | A1 |
20100139662 | Chang | Jun 2010 | A1 |
20110056497 | Scheiner et al. | Mar 2011 | A1 |
20110308526 | Ho et al. | Dec 2011 | A1 |
20230010721 | Barlow et al. | Jan 2013 | A1 |
20130213400 | Barlow et al. | Aug 2013 | A1 |
20140083430 | Matula, Jr. | Mar 2014 | A1 |
20150190602 | Barlow et al. | Jul 2015 | A1 |
20160074613 | Davidson | Mar 2016 | A1 |
20180318540 | Barlow et al. | Nov 2018 | A1 |
20200376222 | Barlow et al. | Dec 2020 | A1 |
20200376223 | Barlow et al. | Dec 2020 | A1 |
20210030992 | Barlow et al. | Feb 2021 | A1 |
20210275768 | Barlow | Sep 2021 | A1 |
20220040433 | Barlow et al. | Feb 2022 | A1 |
Number | Date | Country |
---|---|---|
2009902524 | Jun 2009 | AU |
2009906101 | Dec 2009 | AU |
2010902359 | May 2010 | AU |
1919376 | Feb 2007 | CN |
101237902 | Aug 2008 | CN |
101252965 | Aug 2008 | CN |
40 04 157 | Apr 1991 | DE |
0634186 | Aug 2000 | EP |
2 385 533 | Aug 2003 | GB |
2011-104096 | Jun 2011 | JP |
WO 03076020 | Sep 2003 | WO |
WO 2004052438 | Jun 2004 | WO |
WO 2005063328 | Jul 2005 | WO |
2006130903 | Dec 2006 | WO |
WO 2007008725 | Jan 2007 | WO |
WO 2007130067 | Nov 2007 | WO |
WO 2007133332 | Nov 2007 | WO |
WO 2007139531 | Dec 2007 | WO |
WO 2008007985 | Jan 2008 | WO |
WO 2009052560 | Apr 2009 | WO |
WO 2009108995 | Sep 2009 | WO |
2010067235 | Jun 2010 | WO |
WO 2010135785 | Dec 2010 | WO |
WO 2010139014 | Dec 2010 | WO |
2012040791 | Apr 2012 | WO |
WO 2012040792 | Apr 2012 | WO |
Entry |
---|
Statement of Case dated Feb. 28, 2022 filed in NZ Application No. 761751 (13 pages). |
Amended Notice of Opposition without markups dated Feb. 28, 2022 filed in NZ Application No. 761751 (2 pages). |
Amended Notice of Opposition with markups dated Feb. 28, 2022 filed in NZ Application No. 761751 (3 pages). |
Letter to Patent Office Proceeding No. 6306 dated Feb. 28, 2022 filed in NZ Application No. 761751 (12 pages). |
Office Action dated Jul. 13, 2021 issued in U.S. Appl. No. 17/076,368 (37 pages). |
First Examination Report dated Aug. 17, 2021 issued in New Zealand Application No. 777323 (1 page). |
U.S. Appl. No. 17/076,368, filed Oct. 21, 2020 of Barlow et al., entitled “Patient Interface Systems,” 250 pages. |
U.S. Appl. No. 16/994,904, filed Aug. 17, 2020 of Barlow et al., entitled “Patient Interface Systems,” 211 pages. |
U.S. Appl. No. 16/997,189, filed Aug. 19, 2020 of Barlow et al., entitled “Patient Interface Systems,” 245 pages. |
Extended European Search Report dated May 18, 2020 issued in European Application No. 19207219.7 (10 pages). |
Further Examination Report dated Mar. 8, 2019 issued in New Zealand Application No. 746885 (2 pages). |
Office Action dated Jun. 29, 2018 issued in European Application No. 11827828.2 (4 pages). |
Further Examination Report dated Sep. 18, 2017 issued in New Zealand Application No. 728600 (3 pages). |
First Examination Report dated May 9, 2017 issued in New Zealand Application No. 728600 (2 pages). |
First Examination Report dated Nov. 9, 2015 issued in New Zealand Application No. 713455 (2 pages). |
Extended Search Report dated Mar. 31, 2017 issued in European Application No. 11827828.2 (8 pages). |
Notice of Allowance dated Jan. 23, 2017 issued in Japanese Application No. 2013-530493 (3 pages). |
Further Examination Report dated Dec. 13, 2016 issued in New Zealand Application No. 713455 (2 pages). |
Office Action dated May 9, 2016 issued in Japanese Application No. 2013-530493 with English Translation (6 pages). |
Notification of Third Office Action dated Oct. 10, 2015 issued in Chinese Application No. 201180047871.3 with English language translation (22 pages). |
Notice of Reasons for Rejection dated Aug. 3, 2015 issued in Japanese Application No. 2013-530493 with English translation (8 pages). |
Notification of Second Office Action dated Apr. 10, 2015 issued in Chinese Application No. 201180047871.3 with English translation (26 pages). |
International Search Report for PCT/AU2011/001258 dated Dec. 13, 2011. |
First Examination Report issued in corresponding New Zealand Application No. 625429, dated Jun. 18, 2014. |
Notification of First Office Action dated Nov. 4, 2014 issued in Chinese Application No. 201180047871.3. |
Deadline for Counterstatement dated May 30, 2023 issued in New Zealand Application No. 780432 citing Amended Notice of Opposition without markups dated Jan. 27, 2023 filed in NZ Application No. 780432, Amended Notice of Opposition with markups dated Jan. 27, 2023 filed in NZ Application No. 780432, Amended Statement of Case without markups dated Mar. 20, 2023 filed in NZ Application No. 780432, and Amended Statement of Case with markups dated Mar. 20, 2022 filed in NZ Application No. 780432 (2 pages). |
Deadline for Counterstatement dated Jan. 31, 2024 issued in New Zealand Application No. 761751 (2 pages). |
Proceeding Halt dated Jan. 31, 2024 issued in New Zeland Application No. 761751 (1 page). |
Notice of Opposition to Amendment to Specification Under Section 38 dated Jan. 22, 2024 by Fisher & Paykel Healthcare Limited in New Zealand Application No. 761751 (9 pages). |
Proceeding Correspondence dated Jan. 23, 2024 issued in New Zealand Application No. 761751 (2 pages). |
Number | Date | Country | |
---|---|---|---|
20230226301 A1 | Jul 2023 | US |
Number | Date | Country | |
---|---|---|---|
61528524 | Aug 2011 | US | |
61457981 | Jul 2011 | US | |
61443623 | Feb 2011 | US | |
61388357 | Sep 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17933504 | Sep 2022 | US |
Child | 18188905 | US | |
Parent | 17509221 | Oct 2021 | US |
Child | 17933504 | US | |
Parent | 17330490 | May 2021 | US |
Child | 17509221 | US | |
Parent | 16032722 | Jul 2018 | US |
Child | 17330490 | US | |
Parent | 14645457 | Mar 2015 | US |
Child | 16032722 | US | |
Parent | 13876624 | US | |
Child | 14645457 | US |